7 Firms Steer GSK's £3B India Unit Sale, $5B Oncology Buy
GlaxoSmithKline on Monday said it will sell its Indian consumer health unit and holdings in other Asian markets to Unilever in a £3.1 billion ($3.9 billion) deal, and at the same...To view the full article, register now.
Already a subscriber? Click here to view full article